Stay updated on Risankizumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Risankizumab in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed. This appears to be a minor version-label update and does not modify study content or functionality.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.4.2 was added; the prior Notice about government funding lapse and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedAdded a government funding notice banner and updated the site revision from v3.4.0 to v3.4.1. These changes are cosmetic and do not alter the study content.SummaryDifference0.2%

- Check56 days agoChange DetectedMinor UI/text tweaks were made: a glossary display option, capitalization updates for QC-related fields and No FEAR Act data, and a new revision tag (v3.4.0). These edits do not affect study content, eligibility criteria, results, or user workflow.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision history updated: added Revision v3.3.4 and removed Revision v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Atopic Dermatitis Clinical Trial page.